BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.77−0.02 (-2.06%)
Close on Nov 18, 2026Market cap $11.69MP/E –Yield –
BioCardia net income
Net income is the profit left for shareholders after every expense, interest and tax.
BioCardia's net income for the twelve months ending Jun 30, 2026 was -$7.34M. For fiscal 2025 it was -$8.23M. The highest annual figure on record is $9.66M in fiscal 2011.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.23M | – |
| FY2024 | Dec 31, 2024 | -$7.95M | – |
| FY2023 | Dec 31, 2023 | -$11.57M | – |
| FY2022 | Dec 31, 2022 | -$11.91M | – |
| FY2021 | Dec 31, 2021 | -$12.62M | – |
| FY2020 | Dec 31, 2020 | -$15.00M | – |
| FY2019 | Dec 31, 2019 | -$14.71M | – |
| FY2018 | Dec 31, 2018 | -$13.99M | – |
| FY2017 | Dec 31, 2017 | -$12.31M | – |
| FY2016 | Dec 31, 2016 | -$10.31M | – |
| FY2015 | Dec 31, 2015 | -$6.70M | -2962.0% |
| FY2014 | Dec 31, 2014 | $234.00K | +1131.6% |
| FY2013 | Dec 31, 2013 | $19.00K | -93.8% |
| FY2012 | Dec 31, 2012 | $305.00K | -96.8% |
| FY2011 | Dec 31, 2011 | $9.66M | – |
| FY2010 | Dec 31, 2010 | -$11.51M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.61M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.26M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.71M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.74M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.07M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.50M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.03M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.50M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.46M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.71M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.49M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.99M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.57M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.59M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.50M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.79M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.75M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.54M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.22M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.49M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.00M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.95M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.88M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.58M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.25M | – |
See a number that looks wrong?